DOCSLIB.ORG

Copyrighted Material

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Copyrighted Material Index abdominal pain 11–13 benign prostatic obstruction congenital renal anomalies 10 female patients 29–31, 32 ablative therapy, renal cancer 61 (BPO) 28, 29 continuous urinary incontinence filling, bladder 45 acute on chronic retention beta-3 agonists 29, 42, 43, 45 41 finasteride 29 31, 32 beta human chorionic contrast materials 9 flexible cystoscopy 37, 84, 85 acute urinary retention (AUR) gonadotrophin (bHCG) cranberry products 37 flexible endoscopes 84, 85 13, 27, 31–32 66 cremasteric reflex 12 flexible ureterorenoscopy (FURS) advanced trauma life support bilharzia (schistosomiasis) cryotherapy 59 18, 20, 84, 85 (ATLS) algorithms 38, 39, 63 Cusco’s speculum 6, 7 flow rate test 8, 10, 28 76, 77 biofeedback 43 cystectomy/cysto-prostatectomy fluid intake 37, 73 alpha-adrenoreceptor blockers biopsy 9–10, 59, 61 63 fluid replacement 23 19, 29 bladder 11, 12, 25–45, 77 cystine stones 17 foreskin 5, 49, 72, 73 alpha-fetoprotein (AFP) 66 bladder cancer 62, 63, 68, 69 cystitis 12, 35, 37 Fournier’s gangrene 38, 39, 49 5-alpha reductase inhibitors bladder compliance 45 cystoscopy 31, 69, 84, 85 frequency 27 (5ARIs) 29, 32 bladder diary 28, 30, 40, 41 frequency/volume chart 28 alprostadil 55 bladder injuries 76, 77 da Vinci robotic system 84, 85 functional enquiry 2, 3 American Association for the bladder outflow obstruction desmopressin 31 furosemide 89 Surgery of Trauma (BOO) 26, 27 detrusor overactivity 29, 30, 40, (AAST) renal trauma bladder pain 11, 12 41, 44, 45, 77 genetic studies 53 grades 78, 79 bladder perforation 77, 89 detrusor sphincter dyssynergia genital examination 4–7, 53 analgesia, urolithiasis 19 bladder training 31, 43, 45 (DSD) 30, 45, 77 germ cell tumours 67 andrology 47–55 blood tests 21, 23, 28 diathermy 86, 87 Gleason score 58, 59 anterior abdomen examination body mass index (BMI) digital rectal examination (DRE) glucose tests 28 12 20, 30, 31, 41 4, 5, 11, 12, 27, 53 gonadoblastoma 67 antibiotics 36, 37, 39, 65 bone scan 59 dimercaptosuccinic acid (DMSA) gonadotropin-releasing sensitivity testing 34, 35 Bosniak classification 60 renogram 10 hormone agonists 53 anticholinergic receptor botulinum toxin A 31, 42, 43, 45 distal chip endoscopes 84, 85 gonorrhoea 39 blockers (antimuscarinics) Bowen’s disease 65 diuresis 23, 32 Gram staining 34, 35 29, 31, 42, 43, 45 brachytherapy 59 dorsal artery 55 groin examination 12 antimuscarinics bulbocavernosus reflex (BCR) 5 double-voiding 37 (anticholinergics) 29, 31, bulbo-urethral artery 55 doxycycline 39 haematuria 13, 33, 68–69, 79, 83 42, 43, 45 bulking agents 43 drug history 3, 27, 30, 41 heart failure 51 anti-oestrogens 53 drug-induced conditions 17, 32 hesitancy 27 antioxidants 53 calcium oxalate stones 17 dutasteride 29 high intensity focused aortic aneurysm 12 calcium phosphate stones 17 ultrasound 59 appendicitis 12 Candida albicans 35 electrocautery 87 high pressure chronic retention artificial urinary sphincter carcinoma in situ (CIS) 63, 64 embryonal cell carcinoma 67 (HPCR) 32 (AUS) 42, 43 catheters 23, 33, 77, 82, 83 endoscopic equipment 84, 85 history-taking 2–3 ascitic tap 37 cavernous artery 55 end voided detrusor pressure 32 HIV 73, 89 assisted reproduction techniques cavotomy 61 energy sources 86, 87 holmium laser enucleation of the (ART) 53 cervical erosion 7 epididymal cyst 4, 50, 51 prostate (HoLEP) 29 asthenospermia 53 cervicitis 7 epididymis 5, 49, 53 holmium: yttrium-aluminium atrophic vaginitis 7 cervixCOPYRIGHTED inspection 7 epididymitis MATERIAL 4, 12, 49 garnet (Ho: YAG) laser ‘aubergine penis’ 78, 79 chaperone 5, 49 epididymo-orchitis 4, 39, 49 29, 86, 87 augmentation ‘clam’ cystoplasty chemolysis 19 equipment 81–89 hormonal assessment 53 43, 45 chemo-radiation 63 erectile dysfunction (ED) hormone manipulation 59 autologous fascial sling 43 chemotherapy 59, 63, 65 53, 54–55 human chorionic gonadotrophin, autonomic dysreflexia 45 chlamydia 39 erection 54, 55 beta (bHCG) 66 azoospermia 53 chronic retention 31, 32–33, 41 erythroplasia of Queyrat 65 hydatid of Morgagni torsion 49 ciprofloxacin 39 Escherichia coli 34, 35 hydrocele 4, 5, 12, 50, 51 bacteriuria 35 circumcision 65, 73, 88, 89 external genitalia examination, hydronephrosis 11, 13, 21, 23 balanitis xerotica obliterans clean intermittent female 6, 7, 41 hydro-ureteronephrosis 22, 23, (BXO) 72, 73 self-catheterisation extracorporeal shock wave 32, 33 Bartholin’s abscess 7 (CISC) 32, 33, 45 lithotripsy (ESWL) hypercalciuria 17 Bartholin’s gland 6, 7 computed tomography (CT) 13, 18, 19–20, 86, 87 hyperoxaluria 17 behavioural therapies 43 37, 61, 68, 69, 76, 78, 79 hypertension 69, 79 benign prostatic hyperplasia computed tomography (CT) family history, prostate cancer 59 hyperuricosuria 17 (BPH) 26, 27, 89 urogram 8, 9 female genital examination 6–7 hypocitraturia 17 Urology at a Glance, First Edition. Edited by Hashim Hashim and Prokar Dasgupta. © 2017 by John Wiley & Sons, Ltd. Published 2017 by John Wiley & Sons, Ltd. Companion website: www.ataglanceseries.com/urology 90 bindex 90 18 November 2016 3:14 PM hyponatraemia 89 mixed urinary incontinence phosphodiesterase E-5 inhibitors scrotal swelling 5, 48–51 hypospadias 72, 73 (MUI) 41 (PDE-5i) 29, 55 scrotal ultrasound 51, 66 hypotension 79 MRI, prostate cancer 58 physiological diuresis 23, 32 scrotum 4, 5, 12, 48, 49 hypothalamic–pituitary–gonadal muscarinic receptors 29 physiological phimosis 73 Seldinger technique 82, 83 (HPG) axis 52, 53 polyuria 41 semen analysis 52, 53 necrotic fasciitis of the perineum post-decompression haematuria seminoma 62, 67 immunotherapy 61, 63 38, 39, 49 33 semi-rigid endoscopes 85 impotence 53, 54–55 neodymium: yttium aluminium post-micturition dribbling 27 semi-rigid ureteroscopes 85 incomplete bladder emptying 27 garnet laser 86 post-micturition symptoms 26, sepsis 19 infection stones 17 nephrectomy 61 27, 30 Sertoli cell tumour 67 infra-trigonal (infra-vesical) nephroscope 85 post-obstructive diuresis (POD) sexually transmitted infections obstruction 22, 23 neurogenic detrusor overactivity 22, 23 (STIs) 39 inguinal hernia 12 44, 45, 77 post-prostatectomy incontinence sildenafil (Viagra) 55 inguino-scrotal hernia 51 neurogenic overactive bladder 41 43 Sim’s speculum 6, 7, 30, 41 internal pudendal artery 55 neurological diseases 30 post-renal obstruction 22, 23 sleeve technique 88, 89 International Continence Society neurological examination 27, post-void residual ultrasound 28 social history 3, 30 (ICS) 10, 27, 41 30, 41 PQRST mnemonic 11 speculum examination 6, 7 International Prostate Symptoms neuropathic bladder 44–45 presenting complaint 2, 3 spermatic cord examination Score (IPSS) 28 nocturia 30 priapism 55 12, 53 intracavernous injections 55 nocturnal enuresis 27, 73 procedures 81–89 spermatoceles 51 intra-cytoplasmic sperm nocturnal polyuria 41 prostate 4, 5, 11, 12, 26, 27 sperm granuloma 50, 51 injection (ICSI) 53 non-contrast CT scan (NCCT) prostate biopsy 9–10, 59 spinal cord injury (SCI) 76, 77 intravenous pyelogram 9 9, 11, 13, 16, 19 prostate cancer 12, 58–59 spinal shock 77 intravenous urogram (IVU) non-germ cell tumours 67 prostate-specific antigen (PSA) squamous cell carcinoma 8, 9, 19 non-steroidal anti-inflammatory 28, 58, 59 63, 64, 65 intrinsic sphincter deficiency drugs (NSAIDs) 19 prostatism see lower urinary tract Staphylococcus spp. 34, 35 (ISD) 41 symptoms (LUTS) storage symptoms 26, 27, investigations 8–10 oestrogen therapy 31 prostatitis 12, 38, 39 30, 31 ischiocavernosus muscle 55 oligo-astheno-teratozoospermia psychological problems 55 straining 27 (OAT) syndrome 53 pyelonephritis 12, 38, 39 stress urinary incontinence kalium-titanyl phosphate (KTP) oligospermia 53 pyonephrosis 38, 39 (SUI) 41, 43 laser 29, 86 oncocytoma 61 pyuria 35 struvite stones 17 kidney 11, 12, 15–23 open colposuspension 43 subfertility 53 orchidopexy 49, 73 questionnaires 28, 31 suprapontine lesions 44, 45 lactate dehydrogenase (LDH) 66 orchitis 49 suprapubic catheter (SPC) laparoscopy 20, 73, 85 overactive bladder (OAB) 29, 30, radiation exposure 9 82, 83 lasers 18, 29, 86, 87 41, 43 radical prostatectomy 59 suprasacral lesions 44, 45 Leydig cell tumour 67 Oxford scale 7 radiofrequency ablation 61 supra-trigonal (supra-vesical) lifestyle advice/changes 20, 28, oxybutynin 29 radiotherapy 59 obstruction 22, 23 31, 43, 45, 55 rectal examination 5, 6, 7 surgical decompression 19, 23 lithium triborate (LBO) laser 29 paediatric urology 71–73 referrals 28 surveillance, cancers 59, 61 lithotripters 86, 87 pain 11–13, 30, 48–51, 69 reflexes 5, 12, 77 synthetic mid-urethral tape loin pain 49 palliation 59, 65 renal abscess 38, 39 42, 43 long-term catheter (LTC) 32, 33 pathological diuresis 23, 32 renal angiography 69 lower urinary tract 29, 44, 45 patient, relationship with 2, 3 renal cancer 60–61, 68, 69 tadalafil (Cialis) 55 lower urinary tract symptoms pelvic examination 30 renal cell carcinoma (RCC) tension-free vaginal tape (TVT) (LUTS) 26–33, 69 pelvic floor lift 7 60, 61 42, 43 female patients 29–31 pelvic floor muscle training renal failure 21–23 teratoma 67 male patients 26, 27–29 (PFMT) 31, 43, 45 renal pain 11, 12 teratospermia 53 lymphadenopathy 65 pelvic floor strength assessment 7 renal stones 19–20 terminal dribbling 27 lymphatics 5, 62, 64, 65 pelvic fractures 76, 77 renal trauma 78, 79 testicular appendage torsion 49 lymphoma, testicular 67 penectomy 65 renal ultrasound 11, 13, 19, testicular cancer 4, 5, 50–51, 62, penile cancer 64–65 28, 33 66–67 male genital examination 4–5 penile fracture 78, 79 resectoscope 84, 85 testicular examination 4, 5, 12, male infertility 51, 52–53
Load more

Recommended publications
  • Infertility.Pdf
    Harvard-MIT Division of Health Sciences and Technology HST.071: Human Reproductive Biology Course Director: Professor Henry Klapholz IN SUMMARY INFERTILITY INFERTILITY Defined as 1 year of unprotected intercourse during which a pregnancy is not achieved • United States - 15% to 20% of all couples are infertile • Higher in older couples • Rate has remained relatively stable since the early 1980s • Primary - neither partner has achieved a successful pregnancy • Secondary - couples who have achieved a pregnancy previously but are having difficulty currently with conception Estimated 25% of women will experience infertility during their childbearing years • Societal trend toward delayed marriage and childbirth • Greater awareness of treatment options • Increased societal acceptance of infertility as a medical condition Fecundability is the probability of achieving a pregnancy within 1 menstrual cycle • Fecundability of a “normal” couple (<35 years) is approximately 25% • 3 months, 57% of couples achieved pregnancy • 6 months, 72% • 12 months, 85% • 24 months, 93% Initial assessment - thorough patient history and physical examination Evaluate for evidence of systemic disease, genetic abnormalities, or androgen dysfunction. Female partner - specific areas requiring extra attention • Body mass index • Distribution of body fat • Breast formation and galactorrhea, • Hair pattern (hirsutism or virilization) • Focal neurologic findings (anosmia, visual field impairments) • Assessment of the pelvis o Anomalies of the external genitalia, vagina, or
    [Show full text]
  • Original Article Severe Teratozoospermia Associated with Severe Oligospermia Affects Clinical Outcome in Human ICSI Cycles
    Int J Clin Exp Med 2019;12(7):9324-9334 www.ijcem.com /ISSN:1940-5901/IJCEM0094152 Original Article Severe teratozoospermia associated with severe oligospermia affects clinical outcome in human ICSI cycles Yuan Xu1*, Di Sun1*, Wei Chen1, Jian Sun1, Yi-Xia Yang1, Yu Wu1, Zheng Li1, Zhen-Bo Zhang1,2 1The Reproductive Medicine Center, Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai 200080, China; 2Department of Obstetrics and Gynecology, Shanghai First People’s Hospital, Baoshan Branch, Shanghai 201900, China. *Equal contributors. Received March 20, 2019; Accepted May 13, 2019; Epub July 15, 2019; Published July 30, 2019 Abstract: This study retrospectively investigated the effects of obvious head shape defect in sperm on embryo development and pregnancy outcome. Couples with severe oligospermia (total sperm count was less than several hundred, thus not enough for morphological assessment) were divided into two groups based on morphological ob- servation of sperm head. Group 1 (N=45): sperm with obvious head shape defects (large or small, tapered, pyriform and amorphous head defects). Group 2 (N=166): sperm with “good looking head shape”. The parameters of em- bryo development and pregnancy outcome were compared between the two groups. There were lower fertilization rates, availablity rate, high-quality embryo rate and cumulative live birth rate and higher miscarriage rate in Group 1 when compared with Group 2. No birth defects in the two groups were reported in the clinic. Embryo development and pregnancy outcome with fresh versus frozen-thawed sperm were similar in two groups. However, poor embryo development and pregnancy outcome were found in the obvious head shape defect sperm group regardless of us- ing fresh or frozen-thawed sperm.
    [Show full text]
  • Handbook of Urology Urology Edited by J
    HANDBOOK OF Urology Urology Edited by J. Kellogg Parsons, John B. Eifler and Misop Han Handbook of Urology Handbook of Urology Edited by J. Kellogg Parsons, MD, MHS, FACS Associate Professor of Urology Moores Comprehensive Cancer Center UC San Diego Health System La Jolla, CA, USA John B. Eifler, MD Resident, Urological Surgery The James Buchanan Brady Urological Institute and Department of Urology The Johns Hopkins School of Medicine Baltimore, MD, USA Misop Han, MD, MS Associate Professor of Urology and Oncology The James Buchanan Brady Urological Institute and Department of Urology The Johns Hopkins School of Medicine Baltimore, MD, USA This edition first published 2014 © 2014 by John Wiley and Sons, Ltd Wiley-Blackwell is an imprint of John Wiley & Sons, formed by the merger of Wiley’s global Scientific, Technical and Medical business with Blackwell Publishing. Registered office: John Wiley & Sons, Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK Editorial offices: 9600 Garsington Road, Oxford, OX4 2DQ, UK The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK 111 River Street, Hoboken, NJ 07030-5774, USA For details of our global editorial offices, for customer services and for information about how to apply for permission to reuse the copyright material in this book please see our website at www.wiley.com/wiley-blackwell The right of the author to be identified as the author of this work has been asserted in accordance with the UK Copyright, Designs and Patents Act 1988. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by the UK Copyright, Designs and Patents Act 1988, without the prior permission of the publisher.
    [Show full text]
  • Role of Male Partners in 100 Infertile Couples
    Original Paper Role of Male Partners in 100 Infertile Couples 2 3 Ara MJ1, Hussain SMB , Rashid MU Abstract Introduction: Approximately 15% of couples are Key-words: Normozoospermia, Oligozoospermia, infertile. Male infertility plays an important role in Azoospermia, infertile couple, subfertile couple. about half of these couples. This study has been done to determine whether sperm morphology and Introduction motility do really affect sperm count or Infertility is a significant medical problem that affects spermatogenesis and at the same time causes a many couples. Infertility is a disease of the problem with fertility. reproductive system defined by the failure to achieve a clinical pregnancy after 12 months or more of Objectives: The objective of this study was to 1 regular unprotected sexual intercourse . Male evaluate a male’s inability to cause pregnancy in a infertility refers to a male’s inability to cause fertile female. pregnancy in a fertile female2. Approximately 15% of couples are infertile1,2,3. Male infertility plays an Materials and Methods: This is a prospective study 1 important role in about half of these couples . Male of 100 diagnosed infertile and subfertile couples in infertility is commonly due to deficiencies in the the age group of 23-58 yrs old male. They were semen and semen analysis is a vital part of selected from 01 March 2013 to 28 Feb 2014 diagnosing male infertility2,4. The volume of the undergoing treatment for infertility in Dhaka CMH. semen sample, approximate number of total sperm On the basis of sperm count the cases were grouped cells, sperm motility/forward progression and percent as follows: Normozoospermia, oligozoospermia & of sperm with normal morphology are measured.
    [Show full text]
  • Medicinal Plants As Potential Male Anti-Infertility Agents: a Review Les Plantes Médicinales Dans Le Traitement De L’Infertilité Chez Le Mâle : Mise Au Point
    Androl. (2009) 19:148-158 DOI 10.1007/s12610-009-0030-2 REVIEW Medicinal plants as potential male anti-infertility agents: a review Les plantes médicinales dans le traitement de l’infertilité chez le mâle : mise au point E.A. Nantia · P.F. Moundipa · T.K. Monsees · S. Carreau © Springer-Verlag 2009 Abstract For millions of couples, the inability to have a child Résumé Pour des millions de couples à travers le monde, is a personal tragedy and a large proportion of childless l’incapacité d’avoir un enfant est vécue comme une tragédie people are confronted with social stigmatization (blame) and personnelle. Une large proportion d’entre eux est confrontée personal frustration. Formerly assigned to women, infertility à des stigmatisations sociales dont les conséquences sont of a couple is nowadays equitably distributed between the multiples. Jadis attribuées à la femme, les causes de two sexes. Among the methods used to treat male infertility l’infertilité d’un couple sont pratiquement équitablement problems, medicinal plants have been used empirically as partagées par des facteurs liés aux deux sexes. Parmi les extracts, decoctions, fractions or semi-purified compounds. différentes méthodes de traitement de l’infertilité masculine These herbal products are used in the treatment of a figurent les plantes médicinales qui sont utilisées parfois dysfunctioning of the libido, sexual asthenia, erection, and empiriquement sous forme d’extraits, de fractions ou de sperm disorders. Pharmacological activities of many of these composés partiellement purifiés dans le traitement des plants have been shown in vitro using cells, in vivo (on difficultés de libido, d’asthénie sexuelle, d’érection et laboratory animals) and human studies.
    [Show full text]
  • Screening Targeted Testis‑Specific Genes for Molecular Assessment of Aberrant Sperm Quality
    1594 MOLECULAR MEDICINE REPORTS 14: 1594-1600, 2016 Screening targeted testis‑specific genes for molecular assessment of aberrant sperm quality XUE XIA LIU*, XIAO FANG SHEN* and FU-JUN LIU Central Laboratory, Yantai Yu Huang Ding Hospital, Qingdao University, Yantai, Shandong 264000, P.R. China Received July 4, 2015; Accepted May 9, 2016 DOI: 10.3892/mmr.2016.5434 Abstract. Teratospermia is a heterogeneous and complex ejaculated spermatozoa are usually observed to have reduced disorder, which is closely associated with male fertility. Genes quantity or poor quality. Diagnosis of male infertility predomi- and gene products associated with teratospermia may serve nantly relies on the traditional evaluation of semen parameters, as targeted biomarkers that help understand the underlying whereas genetic factors are often overlooked. Previous studies mechanisms of male infertility; however, systematic infor- have reported that genetic factors are frequently associated mation on the subject remains to be elucidated. The present with male fertility, and may provide novel insights into the study performed a comparative bioinformatics analysis to understanding of male infertility and the assessment of sperm identify biomarkers associated with sperm quality, particular quality (4-6). focusing on testis‑specific biomarkers. A stepwise screening Spermatozoa are produced in the testes, and their mRNAs approach identified 1,085 testis/epididymis-specific genes maturate during the spermatogenesis process (7). Sperm and 3,406 teratospermia-associated genes, resulting in mRNAs are believed to be silenced following the release of 348 testis-specific genes associated with aberrant sperm sperm from the testes; therefore, changes in the expression quality. These genes were functionally associated with the levels of sperm mRNAs may reflect abnormal spermatogen- reproduction process.
    [Show full text]
  • Effects of Traditional Chinese Medicine on Sperm Parameters with a Focus on DNA Fragmentation: a Literature Synthesis
    Effects of Traditional Chinese Medicine on Sperm Parameters with a Focus on DNA Fragmentation: A Literature Synthesis A Capstone Project Submitted in partial fulfillment of the requirements for the degree Doctor of Acupuncture and Oriental Medicine By Virginia C. Prior, MATCM, L.Ac., Dipl.O.M. Yo San University Los Angeles California December, 2011 3 Abstract This project is a literature synthesis of research done on the possible effects of Traditional Chinese Medicine (TCM) on sperm parameters with a focus on DNA Fragmentation Index (DFI) in an effort to treat male infertility. Research studies and articles were gathered, summarized and qualitative data were extracted for analysis in order to investigate how acupuncture and Chinese herbal medicine may affect sperm, DFI and male infertility. Background and etiologies of DNA fragmentation, poor sperm quality and male infertility were examined. TCM was found to have a positive effect on semen parameters, hormone levels, immune markers and antioxidant levels, potentially facilitating fertilization, pregnancy and live birth rates in both natural conception as well as with the use of Assisted Reproductive Technology (ART). Larger, more controlled studies need to be done. Currently, there are no studies published on the potential effect of TCM on DFI, which might be a valuable investigation to pursue. 4 Table of Contents Title Page ……………………………………………………………………………… 1 Approval Signature Page………………………………………………………………. 2 Abstract………………………………………………………………………………… 3 Table of Contents………………………………………………………………………. 4 List of Tables…………………………………………………………………………... 8 Chapter One: Introduction…….…………………………………………………….. 9 Background and Need for the Project …………………………………………. 9 Male Factor Infertility …………………………………………………. 9 Semen Analysis ………………………………………………………... 9 Sperm DNA Integrity …………………………………………………. 10 Measurement of DNA Damage: Sperm DNA Fragmentation Index (DFI) …………………………………………………………..
    [Show full text]
  • Occupational Exposure Associated with Reproductive Dysfunction
    Journal of J Occup Health 2004; 46: 1–19 Occupational Health Review Occupational Exposure Associated with Reproductive Dysfunction Sunil KUMAR Reproductive Toxicology and Histochemistry Division, National Institute of Occupational Health, India Abstract: Occupational Exposure Associated with as a very sensitive reproduction issue is involved with Reproductive Dysfunction: Sunil KUMAR. exposure to these chemicals. Occupational exposures Reproductive Toxicology and Histochemistry often are higher than environmental exposures, so that Division, National Institute of Occupational Health, epidemiological studies should be conducted on these India—Evidence suggestive of harmful effects of chemicals, on a priority basis, which are reported to occupational exposure on the reproductive system and have adverse effects on reproduction in the related outcomes has gradually accumulated in recent experimental system. decades, and is further compounded by persistent (J Occup Health 2004; 46: 1–19) environmental endocrine disruptive chemicals. These chemicals have been found to interfere with the function Key words: Occupational exposure, Reproductive of the endocrine system, which is responsible for dysfunction, Male reproduction, Female reproduction, growth, sexual development and many other essential Persistent chemicals, Toxic fumes, Solvents, physiological functions. A number of occupations are Pesticides, Metals, Endocrine disruptors being reported to be associated with reproductive dysfunction in males as well as in females. Generally, Human beings
    [Show full text]
  • The Effect of COVID-19 on Spermatogenesis
    The effect of COVID-19 on spermatogenesis Mostafa Kamel ( [email protected] ) Assiut University Hospital https://orcid.org/0000-0002-9754-4957 Abdel Moniem Assiut University Hospital Mohamed Zarzur Assiut University Hospital Adel Kurkar Assiut University Hospital Hosny Behnsawy Assiut University Hospital Research Article Keywords: Covid-19 , Semen analysis , spermatogenesis . Posted Date: February 9th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-201151/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/14 Abstract Background : The viral pandemic of the coronavirus disease 2019 (COVID-19) has become a serious worldwide public health emergency, evolving exponentially. While the main organ targeted in this disease is the lungs, other vital organs may be implicated. The main host receptor of the SARS-CoV-2 is angiotensin converting enzyme 2 (ACE2), a major component of the renin-angiotensin-aldosterone system (RAAS). The ACE2 is also involved in testicular male regulation of steroidogenesis and spermatogenesis. A recent report published in JAMA Network revealed that in an analysis 38 semen samples from COVID‐19 patients pcr +ve. As the SARS-CoV-2 may have the potential to infect the testis via ACE2 and adversely affect male reproductive system. From this point the purpose of this study is how covid-19 affect spermatogenesis. methods: Aim: how covid-19 affect spermatogenesis. Design and setting of the study: a100 patients had been enrolled in the study by a criteria suggesting good semen analysis. two sets of semen analysis done, the rst after 72days of rst positive swab for covid-19 to show changes in semen analysis from normal values in the cycle of spermatogenesis during infection, the other sample after 72 days from the rst sample to show if the changes regress to normal and to compare it with the rst sample.
    [Show full text]
  • Kadın Cinsel Sağlığı”, “Erkek İnfertiltesi” Ve “Erkek Genital Sistemi Sorunları” Ile Ilgili Yayınlar Listesi
    ANDROLOJİ BÜLTENİ TÜRK ANDROLOJİ DERNEĞİ YAYIN ORGANIDIR Türk Androloji Derneği Cemil Aslan Güder Sok. İdil Ap. B Blok D.1 Gayrettepe 34349 Beşiktaş, İstanbul Tel: 0212 288 50 99 Faks: 0212 288 50 98 E-posta: [email protected] Web: www.androloji.org.tr TÜRK ANDROLOJİ DERNEĞİ ADINA SAHİBİ Prof. Dr. Önder Yaman YÖNETİM KURULU ADINA BÜLTEN SORUMLUSU Prof. Dr. Selahittin Çayan SORUMLU YAZI İŞLERİ MÜDÜRÜ VE GENEL YAYIN YÖNETMENİ Prof. Dr. Bar›ş Altay YÖNETMEN YARDIMCILARI Doç. Dr. Cüneyt Adayener Uzm. Dr. Memduh Ayd›n YÖNETİM KURULU Önder Yaman (Başkan) Selahittin Çayan (Genel Yazman) İrfan Orhan (Sayman) Ramazan Aşç› (Üye) Oğuz Ekmekçioğlu (Üye) Mustafa F. Usta (Üye) Muammer Kendirci (Üye) Haziran 2011 Yay›n Türü: Yerel Süreli Say› 45 3 Ayda Bir Yay›nlan›r YÖNETİM KURULU ADINA BÜLTEN SORUMLUSU Prof. Dr. Selahittin ÇAYAN Mersin Üniversitesi T›p Fakültesi Üroloji AD, Mersin SORUMLU YAZI İŞLERİ MÜDÜRÜ VE GENEL YAYIN YÖNETMENİ Prof. Dr. Bar›ş ALTAY Ege Üniversitesi T›p Fakültesi Üroloji AD, İzmir YÖNETMEN YARDIMCILARI Doç. Dr. Cüneyt ADAYENER Gata Haydarpaşa Eğitim Hastanesi Üroloji Kliniği, İstanbul Uzm. Dr. Memduh AYDIN Taksim Eğitim ve Araşt›rma Hastanesi Üroloji Kliniği, İstanbul BİLİMSEL KURUL ERKEK CİNSEL SAĞLIĞI Prof. Dr. Ramazan AŞÇI Ondokuz May›s Üniversitesi T›p Fakültesi Üroloji AD, Samsun Doç. Dr. Ali ATAN Ankara Numune Eğitim ve Araşt›rma Hastanesi, 3. Üroloji Kliniği, Ankara Uzm. Dr. Önder CANGÜVEN Dr. Lütfi K›rdar Kartal Eğitim ve Araşt›rma Hastanesi, 2. Üroloji Kliniği, İstanbul Doç. Dr. Murat ÇAKAN SB Ankara D›şkap› Y›ld›r›m Beyaz›t Eğitim ve Araşt›rma Hastanesi, 2.
    [Show full text]
  • The Effect of Varicocelectomy on Sperm Parameters in Subfertile Men with Clinical Varicoceles Who Have Asthenozoospermia Or Teratozoospermia with Normal Sperm Density
    Hindawi Publishing Corporation ISRN Urology Volume 2013, Article ID 698351, 3 pages http://dx.doi.org/10.1155/2013/698351 Clinical Study The Effect of Varicocelectomy on Sperm Parameters in Subfertile Men with Clinical Varicoceles Who Have Asthenozoospermia or Teratozoospermia with Normal Sperm Density Basri Cakiroglu,1 Orhun Sinanoglu,2 and Ramazan Gozukucuk3 1 Department of Urology, Hisar Intercontinental Hospital, Saray Mahallesi, Siteyolu Caddesi No. 7, Umraniye, 34768 Istanbul, Turkey 2 Department of Urology, Maltepe University Medical School, Maltepe, 34844 Istanbul, Turkey 3 Department of Infectious Diseases and Clinical Microbiology, Hisar Intercontinental Hospital, Saray Mahallesi, SiteyoluCaddesiNo.7,Umraniye,34768Istanbul,Turkey Correspondence should be addressed to Basri Cakiroglu; [email protected] Received 5 July 2013; Accepted 27 August 2013 Academic Editors: J. S. Elder and G. Haidl Copyright © 2013 Basri Cakiroglu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Background. To compare preoperative and postoperative sperm parameters such as sperm count, motility, and morphology in patients with normal sperm concentration with teratozoospermia and asthenozoospermia. Materials and Methods. Hundred and six patients with varicocele associated with male infertility over a 5-year period were included into the study. Pre- and postvaricocelectomy seminal fluid parameters evaluation according to the World Health Organization (WHO) criteria was performed at 4–6-month intervals. Results. One hundred and six patients met the criteria. The mean age of patients was 24.53 ± 8.13. The mean duration of infertility was 3.6 years (range: 1.5–6.3).
    [Show full text]
  • Review Article Male Infertility: Causes and Optimal Evaluation Md
    ............ REVIEW ARTICLE MALE INFERTILITY: CAUSES AND OPTIMAL EVALUATION MD. ABUL HOSSAIN1, MD. FAZAL NASER1, MD. SHAFIQUL AZAM1, MD. WALIUL ISLAM2, NITAI PADA BISWAS2, AKM MUSA BHUIYAN3, MOHAMMAD SALAHUDDIN FARUQUE4 1Dept. of Urology, Shaheed Suhrawardy Medical College, 2Dept. of Urology, National Institute of Kidney Diseases and Urology, 3Dept. of Urology, Dhaka Medical college, 4Dept. of Urology, BSMMU Abstract Objective: To find out the optimum evaluation tools for male infertility. Methods: Hinari database were searched for articles related to male infertility for review to find out how a male infertile patient can be evaluated optimally.EUA guidelines on Male Infertility and AUA best practice statement on Optimal Evaluation of the Infertile Male updated on 2010 were also considered for review. Results: Initially thirty five articles were obtained and finally twenty eight articles were considered for review. Some cross references were considered to be cited in the reference section. We have mentioned in this review the evaluation tools those are necessary for male factor infertility at the optimum. Conclusion : As male infertility problem are increasing so optimum evaluation should be carried out to diagnose every possible underlying cause. Key Words: Male infertility,optimum evaluation,investigation, Epidemiology. Bangladesh J. Urol. 2016; 19(1): 43-48 Introduction: The prevalent rate varies between and within countries. For instance, in the United Kingdom and the United The World Health Organization currently defines infertility States of America it is estimated to be 6% and 10% as the inability of a sexually active couple (at least three respectively[4] . Male infertility is increasing on a global times per month), not using contraception, to achieve level is controversial and challenging to confirm [5,6].
    [Show full text]